Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003

Rheumatology

Volumn 45, Issue 2, 2006, Pages 187-191

  Alamanos, Y ^a   Tsifetaki, N ^a   Voulgari, P V ^a   Venetsanopoulou, A I ^a   Siozos, C ^b   Drosos, A A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Epidemiology; Incidence; Mortality; Prevalence; Sj gren's syndrome

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRY EYE; FEMALE; GREECE; HOSPITAL PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT; PATIENT REFERRAL; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SJOEGREN SYNDROME; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; XEROSTOMIA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC METHODS; FEMALE; GREECE; HUMANS; MALE; MIDDLE AGED; SJOGREN'S SYNDROME;

EID: 31544442739     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei107     Document Type: Article

References (35)

1. Moutsopoulos HM, Youinou P. New developments in Sjögren's syndrome. Curr Opin Rheumatol 1991;3:815-22.
2. Moutsopoulos HM. Sjögren's syndrome: Autoimmune epithelitis. Clin Immunol Immunopathol 1994;72:162-5.
3. Moutsopoulos HM, Webber BL, Vlagopoulos TP, Chused TM, Decker JL. Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med 1979;66:733-6.
4. Thomas E, Hay EM, Hajeer A, Silman AJ. Sjögren's syndrome: A community-based study of prevalence and impact. Br J Rheumatol 1998;37:1069-76.
5. Tensing EK, Solovieva SA, Tervahartiala T et al. Fatigue and health profile in sicca syndrome of Sjögren's and non-Sjögren's syndrome origin. Clin Exp Rheumatol 2000;19:313-6.
6. Strombeck B, Ekdahl C, Manthorpe R, Wikstrom I, Jacobsson L. Health-related quality of life in primary Sjögren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scand J Rheumatol 2000;29:20-8.
7. Bowman SJ, Booth DA, Platts RG. Measurement of fatigue and discomfort in primary Sjögren's syndrome using a new questionnaire tool. Rheumatology 2004;43:7584.
8. Tomsic M, Logar D, Grmek M, Perkovic T, Kveder T. Prevalence of Sjögren's syndrome in Slovenia. Rheumatology 1999;38:164-70.
9. Dafni UG, Tzioufas AG, Staikos P, Skopouli FN, Moutsopoulos HM. Prevalence of Sjögren's syndrome in a closed rural community. Ann Rheum Dis 1997;56:521-5.
10. Zhang NZ, Shi CS, Yao QP et al. Prevalence of primary Sjögren's syndrome in China. J Rheumatol 1995;22:659-61.
11. Miyasaka N. Epidemiology and pathogenesis of Sjögren's syndrome. Nippon Rinsho 1995;53:2367-70.
12. Pillemer SR, Matteson EL, Jacobsson LT et al. Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc 2001;76:593-9.
13. Plesivcnik Novljan M, Rozman B, Hocevar A, Grmek M, Kveder T, Tomsic M. Incidence of primary Sjögren's syndrome in Slovenia. Ann Rheum Dis 2004;63:874-6.
14. Manthorpe R, Jacobsson LT, Kirtava Z, Theander E. Epidemiology of Sjögren's syndrome, especially its primary form. Ann Med Interne (Paris) 1998;149:7-11.
15. Drosos AA, Andonopoulos AP, Costopoulos JS, Papadimitriou CS, Moutsopoulos HM. Prevalence of primary Sjögren's syndrome in an elderly population. Br J Rheumatol 1988;27:123-7.
16. Jacobsson LT, Axell TE, Hansen BU et al. Dry eyes or mouth - an epidemiological study in Swedish adults, with special reference to primary Sjögren's syndrome. J Autoimmun 1989;2:521-7.
17. Vitali C, Bombardieri S, Moutsopoulos HM et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis 1993;36:340-7.
18. Vitali C, Moutsopoulos HM, Bombardieri S. The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome. Ann Rheum Dis 1994;53:637-47.
19. Vitali C, Bombardieri S, Moutsopoulos HM et al. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: Results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis 1996;55:116-21.
20. Fox RI, Robinson CA, Curd J, Michelson P, Bone R, Howell FV. First international symposium on Sjögren's syndrome: Suggested criteria for classification. Scand J Rheumatol 1986;61(Suppl.):28-30.
21. Homma M, Tojo T, Akizuki M, Yamagata H. Criteria for Sjögren's syndrome in Japan. Scand J Rheumatol 1986;61(Suppl.):26-7.
22. Manthorpe R, Oxholm P, Prause JU, Schiodt M. The Copenhagen criteria for Sjögren's syndrome. Scand J Rheumatol 1986; 61(Suppl.):19-21.
23. Skopouli FN, Drosos AA, Papaioannou T, Moutsopoulos HM. Preliminary diagnostic criteria for Sjögren's syndrome. Scand J Rheumatol 1986;61(Suppl.):22-5.
24. Vitali S, Bombardieri S, Jonsson R et al. Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
25. Drosos AA, Alamanos I, Voulgari PV et al. Epidemiology of adult rheumatoid arthritis in northwest Greece 1987-1995. J Rheumatol 1997;24:2129-33.
26. Alamanos Y, Voulgari PV, Siozos C et al. Epidemiology of systemic lupus erythematosus in a defined area of northwest Greece, 1982-2001. J Rheumatol 2003;30:731-5.
27. Alamanos Y, Papadopoulos NG, Voulgari PV et al. Epidemiology of psoriatic arthritis in northwest Greece, 1982-2001. J Rheumatol 2003;30:2641-4.
28. Alamanos Y, Papadopoulos NG, Voulgari PV, Karakatsanis A, Siozos C, Drosos AA. Epidemiology of ankylosing spondylitis in Northwest Greece, 1983-2002. Rheumatology 2004;43:615-8.
29. Alamanos Y, Tsifetaki N, Voulgari PV et al. Epidemiology of systemic sclerosis in northwest Greece 1981-2002. Semin Arthritis Rheum 2005;34:714-20.
30. Theander E, Manthorpe R, Jacobsson LT. Mortality and causes of death in primary Sjögren's syndrome: A prospective cohort study. Arthritis Rheum 2004;50:1262-9.
31. Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum 2002;46:741-7.
32. Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum 2000;29:296-304.
33. Martens PB, Pillemer SR, Jacobsson LT, O'Fallon WM, Matteson EL. Survivorship in a population based cohort of patients with Sjögren's syndrome, 1976-1992. J Rheumatol 1999;26: 1296-300.
34. Kelly CA, Foster H, Pal B et al. Primary Sjögren's syndrome in north east England - a longitudinal study. Br J Rheumatol 1991;30:437-42.
35. Kruize AA, Hene RJ, van der Heide A et al. Long-term followup of patients with Sjögren's syndrome. Arthritis Rheum 1996;39:297-303.